CTOs on the Move

Jounce Therapeutics

www.jouncetx.com

 
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients through a biomarker-driven approach. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within the human tumor microenvironment to prioritize targets, and then identifies related biomarkers designed to match the right immunotherapy to the right patient. Jounce is developing two clinical-stage programs as well as advancing and building out its broad and wholly-owned discovery pipeline of immuno-oncology targets, including those expressed ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.jouncetx.com
  • 1030 Massachusetts Avenue
    Cambridge, MA USA 02138
  • Phone: 857.259.3840

Executives

Name Title Contact Details
Nathan Doyle
 Associate Director of Information Technology Profile

Funding

Jounce Therapeutics raised $34.9M on 10/29/2020
Jounce Therapeutics raised $56.2M on 03/10/2021

Similar Companies

Signet Diagnostic Imaging

Signet Diagnostic Imaging is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gamma-Dynacare Medical Laboratories

Gamma-Dynacare Medical Laboratories is a Brampton, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CardioDX

The mission of Crescendo Bioscience, Inc. is to enable more effective management of autoimmune and inflammatory diseases by providing quantitative, objective molecular tests and disease information services to rheumatologists and patients. Crescendo Bioscience is currently focused on rheumatoid arthritis (RA), a debilitating, chronic disease affecting over 1.5 million people in the United States and more than 2 million in Europe. Although there is no known cure for RA, multiple therapies are available, with widely differing levels of effectiveness and significant potential toxicities. Choosing the optimal treatment from among these therapeutic alternatives is a tremendous challenge. At Crescendo Bioscience, we are committed to improving rheumatologists’ ability to understand the biology underlying RA and to better determine the status of a patient’s disease. Vectra® DA is the first and only multi-biomarker blood test validated to measure RA disease activity. Vectra DA integrates the concentrations of 12 serum proteins associated with RA disease activity into a single objective score to help physicians make more informed treatment decisions. Crescendo Bioscience has also developed MyRA™, a free mobile app for people living with RA which was designed to empower patients to regularly track multiple aspects (e.g. medications, morning stiffness, joint pain, daily functionality, etc.) of their RA and easily share the information with their physician.

Alberta Prion Research Institute

Alberta Prion Research Institute is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IBT Reference Lab

IBT Reference Lab is a Lenexa, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.